These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15309877)

  • 1. Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus.
    Fountoulakis A; Martin IG; White KL; Dixon MF; Cade JE; Sue-Ling HM; Wild CP
    Dig Dis Sci; 2004 Jun; 49(6):914-9. PubMed ID: 15309877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor expression in the mucosal tissue at the gastroesophageal junction.
    Trowbridge R; Mittal SK; Sharma P; Hunter WJ; Agrawal DK
    Exp Mol Pathol; 2012 Oct; 93(2):246-9. PubMed ID: 22664272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
    Ormsby AH; Vaezi MF; Richter JE; Goldblum JR; Rice TW; Falk GW; Gramlich TL
    Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
    World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
    Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
    Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    Schmidt MK; Meurer L; Volkweis BS; Edelweiss MI; Schirmer CC; Kruel CD; Gurski RR
    Dis Esophagus; 2007; 20(3):212-6. PubMed ID: 17509117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma.
    Segat D; Cassaro M; Dazzo E; Cavallini L; Romualdi C; Salvador R; Vitale MP; Vitiello L; Fassan M; Rugge M; Zaninotto G; Ancona E; Baroni MD
    Histol Histopathol; 2010 May; 25(5):551-60. PubMed ID: 20238294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus.
    Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM
    J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus.
    Clements DM; Oleesky DA; Smith SC; Wheatley H; Hullin DA; Havard TJ; Bowrey DJ
    J Clin Pathol; 2005 May; 58(5):490-2. PubMed ID: 15858119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
    Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
    Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J; Hopwood D; Pringle R; Wormsley KG
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric metaplasia of the proximal esophagus associated with esophageal adenocarcinoma and Barrett's esophagus: what is the connection? Inlet patch revisited.
    Malhi-Chowla N; Ringley RK; Wolfsen HC
    Dig Dis; 2000; 18(3):183-5. PubMed ID: 11279338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot translational study of dietary vitamin C supplementation in Barrett's esophagus.
    Babar M; Abdel-Latif MM; Ravi N; Murphy A; Byrne PJ; Kelleher D; Reynolds JV
    Dis Esophagus; 2010 Apr; 23(3):271-6. PubMed ID: 19930402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
    Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.
    Going JJ; Fletcher-Monaghan AJ; Neilson L; Wisman BA; van der Zee A; Stuart RC; Keith WN
    Neoplasia; 2004; 6(1):85-92. PubMed ID: 15068673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.